Immudex

Immudex develops proprietary Dextramer® reagents that enable sensitive detection, quantification, and characterization of antigen-specific immune cells. Their products are widely used in academic research, biopharma R&D, vaccine development, antibody discovery, cell therapy development—including CAR-T/TCR-T—and have applications across immuno-oncology, infectious disease monitoring/diagnostics (notably CMV), autoimmunity studies, and transplantation. The company’s first CE-marked kit enables enumeration of cytomegalovirus-specific T-cells for clinical diagnostics in Europe. They do not develop therapeutics but provide critical enabling technologies to the life sciences sector.